Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2014
05/01/2014WO2014065341A1 Therapeutic agent for amyotrophic lateral sclerosis
05/01/2014WO2014065012A1 E-cadherin binding agent, protein synthesis inhibitor, cancer cell growth inhibitor, and antitumoral agent
05/01/2014WO2014064697A1 Method of treatment of disease
05/01/2014WO2014064652A2 Stable pharmaceutical composition of peginterferon alpha-2b
05/01/2014WO2014064637A1 Stable pharmaceutical composition of tnfr:fc fusion protein
05/01/2014WO2014064277A1 Vector for liver-directed gene therapy of hemophilia and methods and use thereof
05/01/2014WO2014064203A1 Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesis
05/01/2014WO2014064092A1 Polypeptides capable of cellular internalization
05/01/2014WO2014063753A1 Hyper-active factor ix vectors for liver-directed gene therapy of hemophilia 'b' and methods and use thereof
05/01/2014WO2014063495A1 Rtrail mutant and monomethyl auristatin e conjugate thereof
05/01/2014WO2014063239A1 Peptides and methods for preventing ischemic tissue injury
05/01/2014WO2014063205A1 Use of endocytosis inhibitors and antibodies for cancer therapy
05/01/2014WO2014039074A3 Therapeutic compositions and related methods
05/01/2014WO2014028560A3 T-cell redirecting bispecific antibodies for treatment of disease
05/01/2014WO2014018295A4 Therapeutic anti-virus vlps
05/01/2014WO2014005107A3 Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
05/01/2014WO2014004934A3 Compositions and methods of treating alzheimer's disease
05/01/2014WO2013186793A9 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
05/01/2014WO2013052498A8 Caspase 9 inhibition and bri2 peptides for treating dementia
05/01/2014WO2012178151A3 St6gal i mediated modulation of hematopoiesis
05/01/2014WO2012166653A3 Methods for coupling targeting peptides onto recombinant lysosomal enzymes
05/01/2014WO2012154684A3 Method of preventing development of psoriatic lesions
05/01/2014WO2012145630A3 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
05/01/2014WO2012138879A3 Peptides for the treatment of hearing
05/01/2014WO2012135465A3 Treatment of glaucoma
05/01/2014WO2012135176A3 The use of wnt agents to prevent hypoxic injury
05/01/2014WO2012129427A3 Aromatic-cationic peptides and uses of same
05/01/2014WO2012112677A3 Methods for treating lysosomal acid lipase deficiency
05/01/2014WO2012058292A3 Parathyroid hormone variants and assays related to disease
05/01/2014US20140121363 Bioreactive Agents
05/01/2014US20140121352 Reversible pegylated drugs
05/01/2014US20140121265 Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids
05/01/2014US20140121171 Treatment for muscular dystrophies
05/01/2014US20140121169 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
05/01/2014US20140121166 Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders
05/01/2014US20140121164 Prevention of kidney injury or disease
05/01/2014US20140121163 Mfg-e8 and uses thereof
05/01/2014US20140121162 Freeze-dried formulations of fgf-18
05/01/2014US20140121161 Repairing bruch's membrane with hydrogels
05/01/2014US20140121160 Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
05/01/2014US20140121159 Terminally–functionalized conjugates and uses thereof
05/01/2014US20140121157 Methods for treating progressive cognitive disorders related to neurofibrillary tangles
05/01/2014US20140121156 Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
05/01/2014US20140121152 Active Agent Prodrugs with Heterocyclic Linkers
05/01/2014US20140121115 Custom-made meganuclease and use thereof
05/01/2014US20140120191 Method of treating a disorder associated with sequestered bacteria
05/01/2014US20140120169 Device and method for encapsulation of hydrophilic materials
05/01/2014US20140120161 Vector for oral administration
05/01/2014US20140120156 Compositions and methods for exosome targeted expression
05/01/2014US20140120155 Compositions and Methods for Modulating Hemostasis
05/01/2014US20140120151 Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use
05/01/2014US20140120141 Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
05/01/2014US20140120120 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
05/01/2014US20140120116 Treatment of cancer using smad3 inhibitor
05/01/2014US20140120111 Treatment of autoimmune disorders and infections using antagonists of sgk1 activity
05/01/2014US20140120107 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/01/2014US20140120100 Compositions and methods for preventing erythropoietin-associated hypertension
05/01/2014US20140120097 Generation of new pancreatic beta cells
05/01/2014US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
05/01/2014US20140120080 Method for Treating or Preventing an Inflammatory Disease and/or an Autoimmune Disease
05/01/2014US20140120079 Compositions and Methods for Diagnosing and Treating Diabetic Micro Vascular Complications
05/01/2014US20140120078 Fragmented polymeric compositions and methods for their use
05/01/2014US20140120077 Compositions and Methods for Safe Treatment of Rhinitis
05/01/2014US20140120076 Eosinophil peroxidase compositions and methods of their use
05/01/2014US20140120074 Antimicrobial agents
05/01/2014US20140120059 Immunity inducing agent
04/2014
04/30/2014EP2725105A1 Enzymatic production method for brain-function-improving peptides
04/30/2014EP2725101A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein
04/30/2014EP2725033A1 Method for producing protein preparation
04/30/2014EP2725016A1 Heterocyclic carboxylic acid ester derivative
04/30/2014EP2724733A1 Hydrophobic polymer compound having anticoagulant effect
04/30/2014EP2724725A2 Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same
04/30/2014EP2723869A1 An il-15 and il-15r sushi domain based immunocytokines
04/30/2014EP2723766A2 Glucagon/glp-1 receptor co-agonists
04/30/2014EP2723761A1 Compound and method for modulating opioid receptor activity
04/30/2014EP2723408A1 Bioresorbable wound dressing
04/30/2014EP2723391A2 Fibroblast growth factor receptor inhibition for the treatment of disease
04/30/2014EP2723390A2 Serpina1 sirnas: compositions of matter and methods of treatment
04/30/2014EP2723382A1 Methods and compositions for modulating voltage-gated calcium channel function
04/30/2014EP2723375A2 Materials and methods for modulating immune responses
04/30/2014EP2723370A2 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
04/30/2014EP2723369A2 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
04/30/2014EP2723368A2 St6gal i mediated modulation of hematopoiesis
04/30/2014EP2723367A2 Glucagon/glp-1 receptor co-agonists
04/30/2014EP2723366A1 Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis
04/30/2014EP2723365A1 Compositions and methods for the therapy and diagnosis of cancer
04/30/2014EP2723364A1 Cell secreted proteins for the treatment of myocardial infarction
04/30/2014EP2723363A2 Combination therapy for ischemia
04/30/2014EP2723362A1 NKp46-MEDIATED NK CELL TUNING
04/30/2014EP2723361A1 Methods of treating chronic disorders with complement inhibitors
04/30/2014EP2723360A1 Ccr2 antagonist peptides
04/30/2014EP2723359A2 Methods for treating diabetes with extended release formulations of glp-1 receptor agonists
04/30/2014EP2723354A1 Compositions, uses, and preparation of platelet lysates
04/30/2014EP2723311A2 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
04/30/2014CN103764675A EDAR ligand-derived peptide and uses thereof
04/30/2014CN103764673A Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
04/30/2014CN103764669A Anti-inflammatory pharmaceutical products
04/30/2014CN103764668A Leukemia stem cell targeting ligands and methods of use
04/30/2014CN103764228A Leukotoxin E/D as a new anti-inflammatory agent and microbicide
04/30/2014CN103764173A Compositions and methods for treating skeletal myopathy
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 3163